Stock Movers

On this episode of Stock Movers:

- Oracle (ORCL) fell after giving its long-range financial outlook, suggesting investors anticipated a bigger boost from its investment in AI infrastructure. The company said overall annual revenue would total $225 billion by fiscal 2030, and the cloud infrastructure business would produce $144 billion in sales by then. Investors have expressed concern about the profitability of Oracle's AI effort, but the company said an infrastructure project for AI would have a gross margin of 35%.

- American Express (AXP) reported earnings that beat expectations after unveiling the long-anticipated Platinum credit card refresh last month. Initial demand for the revamped Platinum card exceeded the firm’s predictions, with US Platinum account acquisitions doubling from pre-refresh levels. The firm raised the lower end of its full-year guidance, with revenue now expected to grow 9% to 10% and earnings likely to total $15.20 to $15.50 a share.

- Eli Lilly (LLY) and Novo Nordisk shares fell after President Donald Trump said the price of the diabetes drug Ozempic could come down to just $150 a month. Trump told reporters that the cost of the drug will soon be “much lower” than the current US list price of roughly $1,000 for a month’s supply. The potential price cut could lead to a big hit for Novo and Lilly, which dominate a market expected to top $95 billion by 2030

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Truist Financial (TFC) shares rise after the firm told investors during its earnings conference call that while the bank had no exposure to bankrupt Tricolor Holdings, it has some exposure to First Brands. The bank accounted for this in its non-performing loans, loan loss reserve and 2025 net charge-off guidance, per CFO Mike Maguire.
- Micron (MU) shares falls after a report from Reuters that the chipmaker plans to stop supplying server chips to data centers in China after the business failed to recover from a 2023 government ban on its products in critical Chinese infrastructure.
- Novo Nordisk (NOVO) shares slide after President Donald Trump said the price of the diabetes drug Ozempic could come down to just $150 a month. Talks over the price of weight-loss drugs, including Ozempic, are still ongoing, according to Mehmet Oz, head of the Centers for Medicare and Medicaid Services.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Novo Nordisk (NOVO) shares fall after President Donald Trump said the price of the diabetes drug Ozempic could come down to just $150 a month. Talks over the price of weight-loss drugs, including Ozempic, are still ongoing, according to Mehmet Oz, head of the Centers for Medicare and Medicaid Services.
- State Street (STT) shares drop after the financial manager’s net interest income fell short of expectations in the third quarter. The company’s adjusted earnings per share for the quarter that beat the average analyst estimate.
- Zion (ZION) shares plunge along with Western Alliance after the companies said they were victims of fraud on loans to funds that invest in distressed commercial mortgages. The disclosures add to other recent loan blowups, including subprime auto lender Tricolor Holdings and auto-parts supplier First Brands Group, which triggered losses for some banks.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Shares of pharma giants Eli Lilly (LLY) and Novo Nordisk (NOVOB DC) are falling in premarket trading after President Trump said the price of the blockbuster diabetes drug Ozempic could come down to just $150 a month. The US list price of Ozempic is roughly $1,000 for a month’s supply. Trump told reporters on Thursday that the cost of the drug, made by Novo, will soon be “much lower.” Lilly sells similar treatments, including Mounjaro and Zepbound.
- American Express (AXP) shares moved lower ahead of the US open after Amex reported earnings that beat expectations after unveiling the long-anticipated Platinum credit card refresh last month. The company best known for its premium credit cards reported $421 billion in billed business, or transaction volume on credit cards and other products issued by Amex, for the third quarter. Analysts had expected the New York-based company to report billed business totaling $415.2 billion.reported earnings that beat expectations after unveiling the long-anticipated Platinum credit card refresh last month. The company best known for its premium credit cards reported $421 billion in billed business, or transaction volume on credit cards and other products issued by Amex, for the third quarter. Analysts had expected the New York-based company to report billed business totaling $415.2 billion.
- Shares of Ally Financial (ALLY) follow Fifth Third Bank (FITB) and Truist Financial (TFC) higher in the early session as the three regional lenders posted positive earnings despite a broader rout in bank stocks.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Shares of regional banks Zions Bancorp (ZION) and Western Alliance (WAL) edged lower ahead of the open after the companies said they were the victims of fraud on loans to funds that invest in distressed commercial mortgages, fueling concern that more cracks are emerging in the credit markets.
- Truist Financial (TFC) and Fifth Third Bank (FITB) edged higher in the early session after earnings that came in slightly above consensus estimates.
- Shares of pharma giants Eli Lilly (LLY) and Novo Nordisk (NOVOB DC) are falling in premarket trading after President Trump said the price of the blockbuster diabetes drug Ozempic could come down to just $150 a month. The US list price of Ozempic is roughly $1,000 for a month’s supply. Trump told reporters on Thursday that the cost of the drug, made by Novo, will soon be “much lower.” Lilly sells similar treatments, including Mounjaro and Zepbound.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Rheinmetall and other defence stocks are down on the back of President Trump's announcement of a second summit with Vladimir Putin, aimed at bringing a rapprochement between Russia and Ukraine.
- BBVA rose in early trading after the Spanish lender's 16 billion-euro bid for Banco Sabadell was rejected by 3 quarters of shareholders.
- Pearson gains after the education company reiterated its guidance for the full year, noting its weighting toward the fourth quarter.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- BBVA rose in early trading after the Spanish lender's 16 billion-euro bid for Banco Sabadell was rejected by 3 quarters of shareholders.
- EssilorLuxottica was lifted by growing revenue from the eyewear company’s AI smart-glasses partnership with Meta.
_ Volvo fell the most in six months after the truckmaker warned that a demand slowdown sparked by tariff uncertainty will extend into next year.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

- Shares of regional banks Zion (ZION) and Western Alliance (WAL) tumbled Thursday after the companies said they were the victims of fraud on loans to funds that invest in distressed commercial mortgages, fueling concern that more cracks are emerging in the credit markets. Zions Bancorp sank 12% after it disclosed a $50 million charge-off for a loan underwritten by its wholly-owned subsidiary, California Bank & Trust, in San Diego. And Western Alliance Bancorp tumbled almost 11% after it said it made loans to the same borrowers. Zions and Western Alliance were the biggest decliners in the KBW Bank Index, which posted its steepest drop in six months.

- HP (HPE) shares fell the most in six months after the company gave an outlook for profit and cash flow for its upcoming fiscal year that missed analysts’ estimates, reflecting a margin crunch in the AI era.  Earnings, excluding some items, will be $2.20 to $2.40 a share in the year ending in October 2026. Free cash flow will be $1.5 billion to $2 billion, HPE said Wednesday in a statement. Analysts, on average, projected profit of $2.41 and free cash flow of $2.41 billion, according to data compiled by Bloomberg. The shares declined as much as 11% to $22.39 after markets opened in New York on Thursday, their biggest intraday drop since April 4. The stock had gained 17% this year through Wednesday’s close.

- JB Hunt (JBHT) shares rose as much as 18% on Thursday, the biggest intraday jump since 1998, after the transportation and logistics company reported third quarter earnings that beat the average analyst estimate helped by better cost control measures.  

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

- JB Hunt (JBHT) shares soar after the transportation and logistics company reported third quarter earnings that beat the average analyst estimate helped by better cost control measures. The stock is the best performer in the S&P 500 today, up almost 22%.

- Hewlett Packard Enterprise (HPE) shares fall after the company gave an outlook for profit and cash flow for its upcoming fiscal year that fell short of analysts’ estimates, reflecting a margin crunch in the AI era.

- F5 (FFIV) shares fell as much as 12% in Thursday trading, the most intraday since April 2024, after a senior US official warned of potentially “catastrophic” compromises due what was said to be a breach blamed on state-backed hackers from China.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- JB Hunt (JBHT) shares soar after the transportation and logistics company reported third quarter earnings that beat the average analyst estimate helped by better cost control measures.
- Salesforce (CRM) shares rise after the software company forecasted that revenue growth will accelerate to double digits in the coming years. Salesforce expects $60 billion in annual revenue by the fiscal year ending in January 2030, Chief Financial and Operating Officer Robin Washington said Wednesday during an investor event.
- Western Alliance (WAL) shares fall after news that the firm filed a lawsuit in August alleging fraud by a borrower in failing to provide collateral loans in first position. Western Alliance evaluated existing collateral and believe it covers the obligation, based on “as-is” appraisals.

See omnystudio.com/listener for privacy information.